Florian Markowetz
Florian Markowetz
Cancer Research UK Cambridge Institute
Verified email at - Homepage
Cited by
Cited by
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
C Curtis, SP Shah, SF Chin, G Turashvili, OM Rueda, MJ Dunning, ...
Nature 486 (7403), 346-352, 2012
The evolutionary history of 2,658 cancers
M Gerstung, C Jolly, I Leshchiner, SC Dentro, S Gonzalez, D Rosebrock, ...
Nature 578 (7793), 122-128, 2020
Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions
F De Sousa E Melo, X Wang, M Jansen, E Fessler, A Trinh, ...
Nature medicine 19 (5), 614-618, 2013
Acetylcysteine for prevention of contrast nephropathy: meta-analysis
R Birck, S Krzossok, F Markowetz, P Schnülle, FJ van der Woude, ...
The Lancet 362 (9384), 598-603, 2003
Patterns of immune infiltration in breast cancer and their clinical implications: a gene-expression-based retrospective study
HR Ali, L Chlon, PDP Pharoah, F Markowetz, C Caldas
PLoS medicine 13 (12), e1002194, 2016
Inferring cellular networks–a review
F Markowetz, R Spang
BMC bioinformatics 8, 1-17, 2007
Quantitative Image Analysis of Cellular Heterogeneity in Breast Tumors Complements Genomic Profiling
Y Yuan, H Failmezger, OM Rueda, HR Ali, S Gräf, SF Chin, RF Schwarz, ...
Science Translational Medicine 4 (157), 157ra143-157ra143, 2012
Cancer evolution: mathematical models and computational inference
N Beerenwinkel, RF Schwarz, M Gerstung, F Markowetz
Systematic biology 64 (1), e1-e25, 2015
Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis
RF Schwarz, CKY Ng, SL Cooke, S Newman, J Temple, AM Piskorz, ...
PLoS medicine 12 (2), e1001789, 2015
Copy number signatures and mutational processes in ovarian carcinoma
G Macintyre, TE Goranova, D De Silva, D Ennis, AM Piskorz, M Eldridge, ...
Nature genetics 50 (9), 1262-1270, 2018
Systems-level dynamic analyses of fate change in murine embryonic stem cells
R Lu, F Markowetz, RD Unwin, JT Leek, EM Airoldi, BD MacArthur, ...
Nature 462 (7271), 358-362, 2009
OncoNEM: inferring tumor evolution from single-cell sequencing data
EM Ross, F Markowetz
Genome biology 17, 1-14, 2016
Master regulators of FGFR2 signalling and breast cancer risk
MNC Fletcher, MAA Castro, X Wang, I De Santiago, M O’Reilly, SF Chin, ...
Nature communications 4 (1), 2464, 2013
Regulators of genetic risk of breast cancer identified by integrative network analysis
MAA Castro, I de Santiago, TM Campbell, C Vaughn, TE Hickey, E Ross, ...
Nature genetics 48 (1), 12-21, 2016
Diverse epigenetic strategies interact to control epidermal differentiation
KW Mulder, X Wang, C Escriu, Y Ito, RF Schwarz, J Gillis, G Sirokmany, ...
Nature cell biology 14 (7), 753-763, 2012
Practical and robust identification of molecular subtypes in colorectal cancer by immunohistochemistry
A Trinh, K Trumpi, F De Sousa E Melo, X Wang, JH De Jong, E Fessler, ...
Clinical cancer research 23 (2), 387-398, 2017
Phylogenetic quantification of intra-tumour heterogeneity
RF Schwarz, A Trinh, B Sipos, JD Brenton, N Goldman, F Markowetz
PLoS computational biology 10 (4), e1003535, 2014
All biology is computational biology
F Markowetz
PLoS biology 15 (3), e2002050, 2017
BitPhylogeny: a probabilistic framework for reconstructing intra-tumor phylogenies
K Yuan, T Sakoparnig, F Markowetz, N Beerenwinkel
Genome biology 16, 1-16, 2015
HTSanalyzeR: an R/Bioconductor package for integrated network analysis of high-throughput screens
X Wang, C Terfve, JC Rose, F Markowetz
Bioinformatics 27 (6), 879-880, 2011
The system can't perform the operation now. Try again later.
Articles 1–20